These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20935165)

  • 1. Do engineered natriuretic peptides have greater therapeutic potential than do native peptides?
    From AH
    Cardiovasc Res; 2010 Dec; 88(3):391-2. PubMed ID: 20935165
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway.
    Kilic A; Rajapurohitam V; Sandberg SM; Zeidan A; Hunter JC; Said Faruq N; Lee CY; Burnett JC; Karmazyn M
    Cardiovasc Res; 2010 Dec; 88(3):434-42. PubMed ID: 20679416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intravenous vasodilators in acute heart failure management.
    Piper S; McDonagh T
    Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for the clinical use of cardiac natriuretic peptides.
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ;
    Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of BNP in heart failure. Shortages of a current review reflect th complexity of the problem].
    Lindstedt G; Alehagen U; Dahlström U
    Lakartidningen; 2004 Feb; 101(8):688-9. PubMed ID: 15024944
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential future therapies: natriuretic peptides.
    Lisy O; Burnett JC
    Coron Artery Dis; 1999 Sep; 10(6):389-94. PubMed ID: 10474789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide therapy for decompensated heart failure.
    Rempher KJ
    Clin Nurse Spec; 2002 May; 16(3):157-9. PubMed ID: 12021617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Natriuretic peptides: their role in diagnosis and therapy].
    Pakuła D; Marek B; Kajdaniuk D; Kos-Kudła B; Borgiel-Marek H; Krysiak R; Gatnar A; Pakuła P
    Endokrynol Pol; 2007; 58(4):364-74. PubMed ID: 18058731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction.
    Richards AM
    Heart; 2009 Aug; 95(16):1299-300. PubMed ID: 19447834
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic potential for existing and novel forms of natriuretic peptides.
    Chen HH; Burnett JC
    Heart Fail Clin; 2006 Jul; 2(3):365-73. PubMed ID: 17386905
    [No Abstract]   [Full Text] [Related]  

  • 15. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular Pleiotropic Effects of Natriuretic Peptides.
    Forte M; Madonna M; Schiavon S; Valenti V; Versaci F; Zoccai GB; Frati G; Sciarretta S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides in therapy for decompensated heart failure.
    Gassanov N; Biesenbach E; Caglayan E; Nia A; Fuhr U; Er F
    Eur J Clin Pharmacol; 2012 Mar; 68(3):223-30. PubMed ID: 21901345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
    Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.